Over the past year, medical centers across the US have removed race adjustment from estimated glomerular filtration rate from serum creatinine (eGFRcr), with many now reporting the “White/other” value for all patients. These changes follow calls to reconsider the use of race in estimating kidney function1 and in medicine broadly.2 We analyzed potential changes in recommended care using eGFRcr with and without race among Black individuals in the US (individuals who are not Black would not be affected).